semaglutide dopamine GLP-1 shown to decrease dopamine. Read that sentence again slowly. Not appetite. Not calories. Not “willpower.” Dopamine. That tiny little molecule sitting in the crossroads of motivation, novelty, pursuit, anticipation, movement, reward Semaglutide Microdose | GoodGirlRx

When you have Type 2 diabetes, the release of the GIP hormone is less efficient and doesnt work effectively

The GLP-1 medications currently approved and used in clinical practice, primarily for the treatment of type 2 diabetes and obesity, include: Semaglutide: Ozempic, Wegovy, Rybelsus Tirzepatide: Mounjaro, Zepbound Liraglutide: Victoza, Saxenda Dulaglutide: Trulicity Exenatide: Byetta, Bydureon Expanding Beyond Obesity The therapeutic potential of GLP-1s extends beyond weight management

Lahey, Ozempic itself doesnt target kidney function, but it does provide secondary benefitslike weight reduction, improved blood sugar control, and lower cardiovascular risksthat can help protect kidney health

Comparative analysis of mRNA targets for human PUF-family proteins suggests extensive interaction with the miRNA regulatory system

All of this to say, the new Perricone MD Essential Fx collection is good